您的位置: 首页 > 农业专利 > 详情页

TREATMENT OF CANCER WITH DIHYDROPYRAZINO-PYRAZINES
专利权人:
SIGNAL PHARMACEUTICALS; LLC
发明人:
RAYMON, Heather,HEGE, Kristen, Mae
申请号:
PH12018502731
公开号:
PH12018502731A1
申请日:
2018.12.21
申请国别(地区):
PH
年份:
2020
代理人:
摘要:
Provided herein are methods for treating or preventing glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status, comprising administering an effective amount of a Dihydropyrazino-Pyrazine Compound to a patient having glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充